Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-02-20 | KalVista Pharmaceuticals, Inc. | Feener Edward P.
(CHIEF SCIENTIFIC OFFICER) |
S | Common Stock | D | 28288 | $14.04 - $14.72 | $397,928 |
| 2024-02-20 | KalVista Pharmaceuticals, Inc. | Yea Christopher
(CHIEF DEVELOPMENT OFFICER) |
S | Common Stock | D | 12053 | $14.11 - $14.11 | $170,124 |
| 2024-02-20 | KalVista Pharmaceuticals, Inc. | Palleiko Benjamin L
(CFO, CBO) |
S | Common Stock | D | 22802 | $14.11 - $14.11 | $321,845 |
| 2024-02-20 | KalVista Pharmaceuticals, Inc. | Audhya Paul K.
(CHIEF MEDICAL OFFICER) |
S | Common Stock | D | 14295 | $14.12 - $14.12 | $201,773 |
| 2024-02-20 | KalVista Pharmaceuticals, Inc. | Crockett Thomas A...
(CEO) |
S | Common Stock | D | 24888 | $14.11 - $14.11 | $351,289 |
| 2024-02-14 | KalVista Pharmaceuticals, Inc. | Feener Edward P.
(CHIEF SCIENTIFIC OFFICER) |
S | Common Stock | D | 28171 | $15.01 - $15.01 | $422,826 |
| 2024-02-14 | KalVista Pharmaceuticals, Inc. | Yea Christopher
(CHIEF DEVELOPMENT OFFICER) |
S | Common Stock | D | 39886 | $15.01 - $15.01 | $598,660 |
| 2024-02-06 | KalVista Pharmaceuticals, Inc. | Shah Nimish P
(AtLeastTenPercentOwner) |
P | Common Stock | A | 86048 | $14.56 - $14.74 | $1,257,827 |
| 2024-02-01 | KalVista Pharmaceuticals, Inc. | Crockett Thomas A...
(CEO) |
S | Common Stock | D | 10000 | $16.18 - $16.81 | $162,198 |
| 2024-01-30 | KalVista Pharmaceuticals, Inc. | Shah Nimish P
(AtLeastTenPercentOwner) |
P | Common Stock | A | 88099 | $14.47 - $14.47 | $1,274,792 |
| 2024-01-25 | KalVista Pharmaceuticals, Inc. | Shah Nimish P
(AtLeastTenPercentOwner) |
P | Common Stock | A | 91804 | $12.73 - $14.22 | $1,289,801 |
| 2024-01-22 | KalVista Pharmaceuticals, Inc. | Shah Nimish P
(AtLeastTenPercentOwner) |
P | Common Stock | A | 99129 | $12.44 - $12.55 | $1,241,683 |
| 2024-01-17 | KalVista Pharmaceuticals, Inc. | Shah Nimish P
(AtLeastTenPercentOwner) |
P | Common Stock | A | 143605 | $12.43 - $12.60 | $1,801,601 |
| 2024-01-11 | KalVista Pharmaceuticals, Inc. | Shah Nimish P
(AtLeastTenPercentOwner) |
P | Common Stock | A | 26246 | $12.68 - $12.73 | $333,778 |
| 2024-01-11 | KalVista Pharmaceuticals, Inc. | Feener Edward P.
(Chief Scientific Officer) |
S | Common Stock | D | 22679 | $13.03 - $13.03 | $295,514 |
| 2024-01-08 | KalVista Pharmaceuticals, Inc. | Shah Nimish P
(AtLeastTenPercentOwner) |
P | Common Stock | A | 137700 | $12.44 - $12.67 | $1,726,455 |
| 2024-01-08 | KalVista Pharmaceuticals, Inc. | Feener Edward P.
(Chief Scientific Officer) |
S | Common Stock | D | 17321 | $13.00 - $13.01 | $225,300 |
| 2023-12-27 | KalVista Pharmaceuticals, Inc. | Crockett Thomas A...
(CEO) |
S | Common Stock | D | 30000 | $12.02 - $12.02 | $360,453 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |